Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-20

FDA Approved: DEFERASIROX — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved the Original Application for Deferasirox from Alembic Pharmaceuticals Limited (ANDA211824).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)